Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analysts have a consensus “Hold” rating on Acadia Healthcare, with seven buys, five holds, two sells and one strong buy among 15 firms. The average 12-month price target is $29.85.
• Several analysts recently raised their price targets, including UBS Group to $39, KeyCorp to $40 and TD Cowen to $36; Jefferies also upgraded the stock from “Hold” to “Buy.”
• Acadia reported quarterly EPS of $0.38, exceeding the $0.35 estimate, while revenue of $865.84 million also topped forecasts. However, revenue declined 0.4% year over year, and the company issued fiscal 2026 EPS guidance of $1.45–$1.60.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned a consensus recommendation of "Hold" from the fifteen ratings firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $29.8462.

A number of research analysts recently issued reports on the stock. UBS Group boosted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. KeyCorp increased their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reiterated a "neutral" rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. Jefferies Financial Group raised Acadia Healthcare from a "hold" rating to a "buy" rating and boosted their price objective for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, TD Cowen upped their target price on Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its stake in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN boosted its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock worth $32,000 after purchasing an additional 1,510 shares in the last quarter. Allworth Financial LP acquired a new stake in Acadia Healthcare in the 2nd quarter valued at $45,000. Global Retirement Partners LLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $68,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company's stock worth $76,000 after buying an additional 5,203 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $28.36 on Friday. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $35.83. The company's 50 day moving average is $30.47 and its 200 day moving average is $26.91. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The company has a market cap of $2.64 billion, a PE ratio of -2.28, a price-to-earnings-growth ratio of 9.13 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. Acadia Healthcare's revenue for the quarter was down .4% compared to the same quarter last year. During the same period last year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, sell-side analysts forecast that Acadia Healthcare will post 1.55 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia's facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.